{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:58:22Z","timestamp":1762300702865},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.nwh.2024.01.005","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T01:52:01Z","timestamp":1714528321000},"page":"242-246","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adjuvanted Vaccine to Prevent Respiratory Syncytial Virus in Adults Ages 60 Years and Older"],"prefix":"10.1016","volume":"28","author":[{"given":"Annmarie","family":"Gennattasio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.nwh.2024.01.005_bib2","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.clinthera.2023.07.015","article-title":"Respiratory syncytial virus vaccine, adjuvanted","volume":"45","author":"Beninger","year":"2023","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.nwh.2024.01.005_bib3","unstructured":"Blum, D. (2023 December 6). Despite new RSV shots, most older adults remain unvaccinated. The New York Times. https:\/\/www.nytimes.com\/2023\/12\/06\/well\/live\/rsv-vaccine-seniors.html"},{"key":"10.1016\/j.nwh.2024.01.005_bib5","unstructured":"Centers for Disease Control and Prevention. (2023, December 7). Vaccine information statements (VISs). https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/"},{"key":"10.1016\/j.nwh.2024.01.005_bib6","unstructured":"Constantino, A. K. (2023a, June 29). CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older. CNBC. https:\/\/www.cnbc.com\/2023\/06\/29\/rsv-vaccine-cdc-recommends-pfizer-gsk-shots-for-older-adults.html"},{"key":"10.1016\/j.nwh.2024.01.005_bib7","unstructured":"Constantino, A. K. (2023b, August 2). GSK sues Pfizer claiming RSV vaccine patent infringement. CNBC. https:\/\/www.cnbc.com\/2023\/08\/02\/gsk-sues-pfizer-for-patent-infringement-over-rsv-vaccines.html"},{"issue":"6452","key":"10.1016\/j.nwh.2024.01.005_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.aav9033","article-title":"A\u00a0proof of concept for structure-based vaccine design targeting RSV in humans","volume":"365","author":"Crank","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.nwh.2024.01.005_bib9","unstructured":"Fryhofer, S. (2023, September 28). CDC guidelines for maternal RSV vaccine and latest FDA approvals with Sandra Fryhofer, MD. American Medical Association. https:\/\/www.ama-assn.org\/delivering-care\/public-health\/cdc-guidelines-maternal-rsv-vaccine-and-latest-fda-approvals-sandra"},{"key":"10.1016\/j.nwh.2024.01.005_bib11","unstructured":"GSK. (2023a, August 17). GSK announces AREXVY, its respiratory syncytial virus (RSV) vaccine, is now available at all major US retail pharmacies [Press release]. https:\/\/us.gsk.com\/en-us\/media\/press-releases\/gsk-announces-arexvy-its-respiratory-syncytial-virus-rsv-vaccine-is-now-available-at-all-major-us-retail-pharmacies\/"},{"key":"10.1016\/j.nwh.2024.01.005_bib12","unstructured":"GSK. (2023b, October 25). New data for Arexvy, GSK\u2019s RSV vaccine, show potential to help protect adults aged 50 to 59 at increased risk for RSV disease. https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/new-data-for-arexvy-show-potential-to-help-protect-adults-aged-50-to-59\/"},{"issue":"14","key":"10.1016\/j.nwh.2024.01.005_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15585\/mmwr.mm7214a1","article-title":"Seasonality of respiratory syncytial virus\u2014United States, 2017\u20132023","volume":"72","author":"Hamid","year":"2023","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"8","key":"10.1016\/j.nwh.2024.01.005_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11081386","article-title":"Prospective attitudes towards respiratory syncytial virus (RSV) vaccination: Validation of a survey instrument among young females in Jordan pending vaccine authorization","volume":"11","author":"Kherfan","year":"2023","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.nwh.2024.01.005_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/QCO.0000000000000917","article-title":"Respiratory syncytial virus infection in the modern era","volume":"36","author":"Ludlow","year":"2023","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1016\/j.nwh.2024.01.005_bib16","series-title":"How synthetic drugs work","first-page":"503","article-title":"Chapter 22\u2014An insight into the agents used for immunomodulation and their mechanism of action","author":"Mandal","year":"2023"},{"issue":"7","key":"10.1016\/j.nwh.2024.01.005_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac300","article-title":"Rates of medically attended RSV among US adults: A systematic review and meta-analysis","volume":"9","author":"McLaughlin","year":"2022","journal-title":"Open Forum Infectious Diseases"},{"issue":"6136","key":"10.1016\/j.nwh.2024.01.005_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"29","key":"10.1016\/j.nwh.2024.01.005_bib19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","article-title":"Use of respiratory syncytial virus vaccines in older adults: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2023","volume":"72","author":"Melgar","year":"2023","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"50","key":"10.1016\/j.nwh.2024.01.005_bib20","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.15585\/mmwr.mm7050a1","article-title":"Report of health care provider recommendation for COVID-19 vaccination among adults, by recipient COVID-19 vaccination status and attitudes\u2014United States, April\u2013September 2021","volume":"70","author":"Nguyen","year":"2021","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"7","key":"10.1016\/j.nwh.2024.01.005_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.nwh.2024.01.005_bib23","unstructured":"Smith, D. G. (2023, August 29). R.S.V. immunizations: Things worth knowing, new options for older adults, pregnant women, and young children. The New York Times, D7."},{"key":"10.1016\/j.nwh.2024.01.005_bib24","unstructured":"Wen, L. S. (2023, October 10). It shouldn\u2019t be so hard for older adults to receive the RSV vaccine. Washington Post. https:\/\/www.washingtonpost.com\/opinions\/2023\/10\/10\/rsv-vaccines-barriers-insurance-coverage-medicare\/"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485124000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485124000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T03:22:49Z","timestamp":1716866569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485124000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1751485124000485"],"URL":"https:\/\/doi.org\/10.1016\/j.nwh.2024.01.005","relation":{},"ISSN":["1751-4851"],"issn-type":[{"value":"1751-4851","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvanted Vaccine to Prevent Respiratory Syncytial Virus in Adults Ages 60 Years and Older","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nwh.2024.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AWHONN","name":"copyright","label":"Copyright"}]}}